SKYE vs. QVCGA
SKYE (Skye Bioscience, Inc) and QVCGA (QVC Group Inc) are both stocks. SKYE operates in Biotechnology (Healthcare), while QVCGA operates in Internet Retail (Consumer Cyclical).
Performance
SKYE vs. QVCGA - Performance Comparison
Loading charts...
Returns By Period
SKYE
- 1D
- 5.02%
- 1M
- -10.75%
- YTD
- 2.71%
- 6M
- -36.36%
- 1Y
- -68.31%
- 3Y*
- -41.13%
- 5Y*
- -54.71%
- 10Y*
- -40.24%
QVCGA
- 1D
- 0.00%
- 1M
- —
- YTD
- —
- 6M
- —
- 1Y
- —
- 3Y*
- —
- 5Y*
- —
- 10Y*
- —
SKYE vs. QVCGA - Yearly Performance Comparison
| 2026 (YTD) | |
|---|---|
SKYE Skye Bioscience, Inc | -9.40% |
QVCGA QVC Group Inc | 0.00% |
Fundamentals
SKYE:
$30.55M
QVCGA:
$2.75M
SKYE:
-$1.45
QVCGA:
-$302.09
SKYE:
$0.00
QVCGA:
$9.23B
SKYE:
-$180.01K
QVCGA:
$2.89B
SKYE:
$10.92M
QVCGA:
$789.00M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
SKYE vs. QVCGA — Risk / Return Rank
SKYE
QVCGA
SKYE vs. QVCGA - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Skye Bioscience, Inc (SKYE) and QVC Group Inc (QVCGA). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| SKYE | QVCGA | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | — | — | |
| Sortino ratioReturn per unit of downside risk | — | — | |
| Omega ratioGain probability vs. loss probability | 0.94 | — | — |
| Calmar ratioReturn relative to maximum drawdown | -0.78 | — | — |
| Martin ratioReturn relative to average drawdown | -1.04 | — | — |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| SKYE | QVCGA | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | -0.59 | — | — |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | -0.42 | — | — |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | -0.29 | — | — |
Sharpe Ratio (All Time)Calculated using the full available price history | -0.36 | — | — |
Drawdowns
SKYE vs. QVCGA - Drawdown Comparison
The maximum SKYE drawdown since its inception was -99.96%, which is greater than QVCGA's maximum drawdown of 0.00%. Use the drawdown chart below to compare losses from any high point for SKYE and QVCGA.
Loading charts...
Drawdown Indicators
| SKYE | QVCGA | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -99.96% | 0.00% | -99.96% |
Max Drawdown (1Y)Largest decline over 1 year | -87.85% | — | — |
Max Drawdown (3Y)Largest decline over 3 years | -96.79% | — | — |
Max Drawdown (5Y)Largest decline over 5 years | -98.66% | — | — |
Max Drawdown (10Y)Largest decline over 10 years | -99.83% | — | — |
Current DrawdownCurrent decline from peak | -99.94% | 0.00% | -99.94% |
Average DrawdownAverage peak-to-trough decline | -94.95% | 0.00% | -94.95% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 65.76% | — | — |
Volatility
SKYE vs. QVCGA - Volatility Comparison
Loading charts...
Volatility by Period
| SKYE | QVCGA | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 28.64% | — | — |
Volatility (6M)Calculated over the trailing 6-month period | 63.38% | — | — |
Volatility (1Y)Calculated over the trailing 1-year period | 115.33% | 0.00% | +115.33% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 130.81% | 0.00% | +130.81% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 137.31% | 0.00% | +137.31% |
Dividends
SKYE vs. QVCGA - Dividend Comparison
Neither SKYE nor QVCGA has paid dividends to shareholders.
Financials
SKYE vs. QVCGA - Financials Comparison
This section allows you to compare key financial metrics between Skye Bioscience, Inc and QVC Group Inc. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
Find the right allocation for SKYE and QVCGA
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer